Prof. McDonnell Quoted in Star Tribune Article on Medtronic Suit

Professor Brett McDonnell was quoted in a Star Tribune article on a securities class action suit against Medtronic. Medtronic shareholders have sued Medtronic claiming that the company inflated its stock value by secretly paying doctors to conceal problems associated with Infuse, a bone-growth product. The judge in the case recently certified the case as a class-action suit. In the Star Tribune article, McDonnell is quoted on the importance of class certification as a stage in a securities fraud suit. “If you don't get a class certification, you're done,” McDonnell said, “because it is not financially feasible to sue individually.”